Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC
CatalYm GmbH
CatalYm GmbH
Compugen Ltd
Rigshospitalet, Denmark
Rush University Medical Center
The Canadian College of Naturopathic Medicine
Tam Anh Research Institute
Grifols Therapeutics LLC
Monash University
SWOG Cancer Research Network
Glonova Pharma Co., Ltd
Brigham and Women's Hospital
Massachusetts General Hospital
St. Louis University
Hope Biosciences Research Foundation
Medigen Biotechnology Corporation
Peking University First Hospital
Peking University First Hospital
Yonsei University
Dharmais National Cancer Center Hospital
Tata Memorial Hospital
Fujian Medical University Union Hospital
University of Illinois at Chicago
Tongji Hospital
Nanjing First Hospital, Nanjing Medical University
China Medical University, China
Hospital Universitario Marqués de Valdecilla
Nova Scotia Health Authority